Invion Ltd has released a press release.
Appendix 4D and Half Year Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
Later from Invion
- Smoking cessation patent allowance and Operational update
- Invion announces no secondary capital raise
- End of Phase 2 Meeting for INV102 (nadolol)
- Phase 2 data presented to American Thoracic Society
- Response to ASX Appendix 4C query
Follow Invion into a list and get an email when it puts out news.
Follow Invion